Archives of Medical Science最新文献_第10页

The systemic inflammation response index (SIRI) is associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. 维持性血液透析患者的全身炎症反应指数（SIRI）与全因死亡率和心血管死亡率相关。

IF 3.3 4区医学

Archives of Medical Science Pub Date : 2024-10-26 eCollection Date: 2025-01-01 DOI: 10.5114/aoms/194534

Qiuhong Shi, Bo Lv, Sheng Feng, Shan Jiang, Ying Zeng, Kai Song

{"title":"The systemic inflammation response index (SIRI) is associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients.","authors":"Qiuhong Shi, Bo Lv, Sheng Feng, Shan Jiang, Ying Zeng, Kai Song","doi":"10.5114/aoms/194534","DOIUrl":"10.5114/aoms/194534","url":null,"abstract":"Introduction: The aim of this study was to investigate the association between the systemic inflammation response index (SIRI) and all-cause and cardiovascular disease (CVD) mortality in maintenance hemodialysis (MHD) patients.Material and methods: 371 MHD patients were included in this retrospective study. Time-dependent receiver operating characteristic (ROC) curve analysis was used to evaluate the predictive value of SIRI. Patients were categorized into two groups based on the median SIRI value. Kaplan-Meier survival analysis was used to compare the difference in survival rate. Cox regression analysis was used to analyze all-cause and CVD mortality risk factors, and nomograms were developed.Results: The average age of the patients was 60.71 ±15.34 years, and the median follow-up was 42 months. 157 patients died. SIRI had predictive value for all-cause and CVD mortality. The AUC of the SIRI to predict all-cause mortality was 0.698, 0.664, 0.713, and 0.900 at 1, 3, 5, and 10 years, respectively. For CVD mortality, the AUC of the SIRI was 0.678, 0.667, 0.717, and 0.906 at 1, 3, 5, and 10 years, respectively. Kaplan-Meier survival analysis showed that patients with high SIRI values had a significantly lower survival rate. Multivariate Cox regression analysis showed that SIRI > 1.88 was an independent risk factor for all-cause and CVD mortality.Conclusions: SIRI can independently predict all-cause and CVD mortality in MHD patients, which has important value for prognosis.","PeriodicalId":8278,"journal":{"name":"Archives of Medical Science","volume":"21 4","pages":"1252-1262"},"PeriodicalIF":3.3,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12509800/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145278751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Association of cataract surgery with risk of dementia: a meta-analysis and systematic review of cohort studies with 720,075 participants. 白内障手术与痴呆风险的关联：一项对720075名参与者的队列研究的荟萃分析和系统回顾。

IF 3 4区医学

Archives of Medical Science Pub Date : 2024-10-25 eCollection Date: 2024-01-01 DOI: 10.5114/aoms/193394

Qin Li, Liangqiong Zhu

引用次数: 0

Diagnostic value of circulating bone turnover markers osteocalcin, cathepsin K, and osteoprotegerin for osteoporosis in middle-aged and elderly postmenopausal women. 循环骨转换标志物骨钙素、组织蛋白酶K和骨保护素对中老年绝经后妇女骨质疏松症的诊断价值。

IF 3 4区医学

Archives of Medical Science Pub Date : 2024-10-25 eCollection Date: 2024-01-01 DOI: 10.5114/aoms/193198

Lei Zhang, Jiaxiang Cheng, Hang Su, Zhaoxia Wang, Weiyi Dai

引用次数: 0

Metabolism score for visceral fat (METS-VF): an innovative and powerful predictor of stroke. 内脏脂肪代谢评分（METS-VF）：一种创新而有力的中风预测指标。

IF 3 4区医学

Archives of Medical Science Pub Date : 2024-10-24 eCollection Date: 2024-01-01 DOI: 10.5114/aoms/193709

Aihua Tan, Shuo Yang, Yi Pan, Qian Lin

引用次数: 0

Serum chemerin level in patients with liver cirrhosis and primary and multifocal hepatocellular carcinoma with consideration of insulin level. 肝硬化、原发性和多灶性肝癌患者血清趋化素水平与胰岛素水平的关系。

IF 3 4区医学

Archives of Medical Science Pub Date : 2024-10-22 eCollection Date: 2024-01-01 DOI: 10.5114/aoms/176674

Monika Pazgan-Simon, Anna Szymanek-Pasternal, Joanna Górka-Dynysiewicz, Anna Nowicka, Krzysztof Simon, Ewa Grzebyk, Michał Kukla

{"title":"Serum chemerin level in patients with liver cirrhosis and primary and multifocal hepatocellular carcinoma with consideration of insulin level.","authors":"Monika Pazgan-Simon, Anna Szymanek-Pasternal, Joanna Górka-Dynysiewicz, Anna Nowicka, Krzysztof Simon, Ewa Grzebyk, Michał Kukla","doi":"10.5114/aoms/176674","DOIUrl":"10.5114/aoms/176674","url":null,"abstract":"Introduction: The aim of the study was to evaluate chemerin levels as a potentially useful marker in diagnosing early-stage hepatocellular carcinoma (HCC) as well as in HCC staging.Material and methods: The cohort comprised 76 patients: 45 people with cirrhosis and HCC (including 13 with a single HCC lesion in the liver and 32 with metastatic lesions/spread of HCC in the liver) and 21 people with isolated cirrhosis. The control group included 10 clinically healthy people.Results: The degree of liver failure in the whole cohort was assessed using the Child-Turcotte-Pugh (CTP) score (class A - 34, class B - 28, class C - 4) and using the MELD score (≤ 12 points - 45 and > 12 points - 21 people). Serum chemerin level in patients with liver cirrhosis only was 53.30 ng/ml, in patients with a single HCC lesion 77.01 ng/ml, and in patients with disseminated HCC 83.58 ng/ml. In the control group, the chemerin level was 82.20 μg/ml. When patients with cirrhosis and with/without HCC were divided according to their CTP scores, the level of chemerin was as follows: class A - 83.90 μg/ml, class B - 61 μg/ml, class C - 30.10 μg/ml. For MELD scores ≤ and > 12 it was 75 μg/ml and 58 μg/ml, respectively. For BCLC staging the results were as follows: A - 20.10 μg/ml, B - 20.20 μg/ml, C -19.44 μg/ml.Conclusions: Chemerin increases with the number of neoplastic lesions and decreases with the progression of liver failure as assessed using the CTP score.","PeriodicalId":8278,"journal":{"name":"Archives of Medical Science","volume":"20 5","pages":"1504-1510"},"PeriodicalIF":3.0,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11623147/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142793974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Aspartate aminotransferase to alanine aminotransferase ratio and short-term prognosis of patients with type 2 diabetes hospitalized for heart failure. 谷草转氨酶与丙氨酸转氨酶比值与2型糖尿病心力衰竭住院患者的短期预后

IF 3 4区医学

Archives of Medical Science Pub Date : 2024-10-22 eCollection Date: 2024-01-01 DOI: 10.5114/aoms/184153

Dan Liu, Li Liu, Nan Li, Yiling Zhou, Hongmei Huang, Jidong He, Heling Yao, Xiangyang Chen, Xiaochi Tang, Miye Wang, Ying Qi, Si Wang, Ye Zhu, Haoming Tian, Zhenmei An, Sheyu Li

{"title":"Aspartate aminotransferase to alanine aminotransferase ratio and short-term prognosis of patients with type 2 diabetes hospitalized for heart failure.","authors":"Dan Liu, Li Liu, Nan Li, Yiling Zhou, Hongmei Huang, Jidong He, Heling Yao, Xiangyang Chen, Xiaochi Tang, Miye Wang, Ying Qi, Si Wang, Ye Zhu, Haoming Tian, Zhenmei An, Sheyu Li","doi":"10.5114/aoms/184153","DOIUrl":"10.5114/aoms/184153","url":null,"abstract":"Introduction: We aimed to explore the prognostic value of the aspartate aminotransferase to alanine aminotransferase (AST/ALT) ratio in non-surgical patients with type 2 diabetes hospitalized for heart failure.Material and methods: Using a large electronic medical record-based cohort of diabetes in China (WECODe), we gathered data on non-surgical hospitalized patients with type 2 diabetes and heart failure from 2011 to 2019. Baseline AST/ALT ratio was calculated. The primary outcomes were all-cause death within 30 days after discharge, composite cardiac events, major acute kidney injury, and major systemic infection. A multivariable Cox proportional regression model was utilized to evaluate the association between the AST/ALT ratio and outcomes.Results: This retrospective cohort included 8,073 patients (39.4% women) with type 2 diabetes hospitalized for heart failure. The median age was 71 years. Higher AST/ALT ratio was associated with higher risks of poor endpoints (with per standard deviation increment in AST/ALT ratio, for death within 30 days after discharge: adjusted hazard ratio [HR] = 1.35, 95% confidence interval [CI], 1.21 to 1.50; for composite cardiac events: HR = 1.18, 95% CI: 1.06 to 1.31). Compared to patients in the lowest quartile for the AST/ALT ratio, those in the highest quartile have elevated risk of death within 30 days after discharge and major systemic infection (HRs [95% CIs] 1.61 [1.18 to 2.19] and 1.28 [1.06 to 1.56], respectively). Subgroup analyses and sensitivity analyses confirmed the robustness of the findings.Conclusions: Type 2 diabetes patients hospitalized for heart failure with the AST/ALT ratio in the highest quartile face a poor short-term prognosis.","PeriodicalId":8278,"journal":{"name":"Archives of Medical Science","volume":"20 5","pages":"1416-1425"},"PeriodicalIF":3.0,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11623178/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142794320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Association between gastroesophageal reflux disease and metabolic syndrome: a bidirectional two-sample Mendelian randomization analysis. 胃食管反流病与代谢综合征之间的关系：双向双样本孟德尔随机分析

IF 3 4区医学

Archives of Medical Science Pub Date : 2024-10-22 eCollection Date: 2024-01-01 DOI: 10.5114/aoms/193708

Tao He, Xiaoling Geng, Xue Lin, Yufei Li, Zhijun Duan

引用次数: 0

Intragastric botulinum toxin injection: a promising alternative for obesity treatment? 胃内肉毒毒素注射：肥胖治疗的一个有希望的选择？

IF 3 4区医学

Archives of Medical Science Pub Date : 2024-10-21 eCollection Date: 2024-01-01 DOI: 10.5114/aoms/178334

Hakan Balbaloglu, Ilhan Tasdoven, Ipek Yorgancioglu

{"title":"Intragastric botulinum toxin injection: a promising alternative for obesity treatment?","authors":"Hakan Balbaloglu, Ilhan Tasdoven, Ipek Yorgancioglu","doi":"10.5114/aoms/178334","DOIUrl":"10.5114/aoms/178334","url":null,"abstract":"Introduction: Over the past 50 years, the rise in obesity has prompted a search for new treatments. Intragastric injections of botulinum toxin A (BT-A), a safer alternative to surgery, show promise in reducing weight and caloric intake by inducing early satiety. This study examines their efficacy for weight loss.Material and methods: From 2021 to 2023, we conducted a retrospective analysis of patients who underwent intragastric BT-A injections in a general surgery endoscopy unit. The inclusion criteria were being aged 18-65 and having a body mass index (BMI) over 25 kg/m2. Patients with specific medical conditions or incomplete records were excluded. We monitored patient weight and BMI values before the procedure and at monthly intervals, with further assessments conducted in the sixth month, including appetite and patient satisfaction.Results: Our study on 67 patients, predominantly female (82.1%), aged 35.5 ±9.0 years with a mean BMI of 33.5 ±3.3 kg/m², examined BT-A injections' effectiveness. 58.2% received injections in both gastric antrum and fundus regions, showing greater weight loss (mean: 10.7 ±7.0 kg) than those treated in the antrum alone. Side effects occurred in 16.4%, with various symptoms. High dietary compliance (80.6%) correlated with weight loss, especially among those reporting intense satiety. Patient satisfaction positively correlated with weight loss, highlighting treatment efficacy and patient response to dual-region injections.Conclusions: Our study suggested that intragastric BT-A injections in the antrum and fundus are effective and safe for satiety and weight loss, with few side effects. Individual responses vary, and diet adherence is crucial. More studies are needed to assess the treatment's efficacy in obesity.","PeriodicalId":8278,"journal":{"name":"Archives of Medical Science","volume":"20 5","pages":"1400-1406"},"PeriodicalIF":3.0,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11623158/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142794418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

CSF1 mediating 3-hydroxyhexanoate in endometrial cancer: a Mendelian randomization study. CSF1介导3-羟基己酸在子宫内膜癌中的作用：一项孟德尔随机研究。

IF 3 4区医学

Archives of Medical Science Pub Date : 2024-10-17 eCollection Date: 2024-01-01 DOI: 10.5114/aoms/193392

Hu Jiazhen, Fan Bozhen

引用次数: 0

Lipoprotein(a) and other risk factors in dyslipidemic patients with and without heart failure. 伴有和不伴有心力衰竭的血脂异常患者的脂蛋白(a)和其他危险因素

IF 3 4区医学

Archives of Medical Science Pub Date : 2024-10-16 eCollection Date: 2024-01-01 DOI: 10.5114/aoms/194684

Joanna Lewek, Bozena Sosnowska, Agata Bielecka-Dąbrowa, Karina Mierczak, Weronika Adach, Maciej Banach

引用次数: 0